Quantum Biopharma Ltd. (QNTM) Cash from Operations (2019 - 2026)

Quantum Biopharma (QNTM) has 7 years of Cash from Operations data on file, last reported at 1668749.0 in Q1 2026.

• Quarterly Cash from Operations rose 60.84% year-over-year to 1668749.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5644918.0 (up 38.4% YoY) and the FY2025 annual result came in at 8237012.0, down 19.79% from the prior year.
• Cash from Operations fell to 1668749.0 in Q1 2026 per QNTM's latest filing, from 305598.0 in the prior quarter.
• The five-year high for Cash from Operations was 9398050.0 in Q2 2022, with the low at 50340664.0 in Q4 2022.
• Average Cash from Operations over 4 years is 3470424.08, with a median of 1668749.0 recorded in 2026.
• Year-over-year, Cash from Operations jumped 63.85% in 2022 and tumbled 221.38% in 2025.
• Quantum Biopharma's Cash from Operations stood at 50340664.0 in 2022, then jumped by 98.34% to 835762.0 in 2024, then surged by 63.43% to 305598.0 in 2025, then plunged by 446.06% to 1668749.0 in 2026.
• Business Quant data shows QNTM's Cash from Operations at 1668749.0 in Q1 2026, 305598.0 in Q4 2025, and 1721476.0 in Q3 2025.